Výsledky vyhledávání - "Broderick, C. L."

Periodical

Design and Synthesis of α-Aryloxy-α-methylhydrocinnamic Acids: A Novel Class of Dual Peroxisome Proliferator-Activated Receptor α/γ Agonists

Publikováno v: Journal of Medicinal Chemistry; May 2004, Vol. 47 Issue: 10 p2422-2425, 4p

Zobrazit plný text záznamu

Periodical

Design and Synthesis of 2-Methyl-2-{4-[2-(5-methyl-2-aryloxazol- 4-yl)ethoxy]phenoxy}propionic Acids: A New Class of Dual PPARα/γ Agonists

Autor: Brooks, D. A., Etgen, G. J., Rito, C. J., Shuker, A. J., Dominianni, S. J., Warshawsky, A. M., Ardecky, R., Paterniti, J. R., Tyhonas, J., Karanewsky, D. S., Kauffman, R. F., Broderick, C. L., Oldham, B. A., Montrose-Rafizadeh, C., Winneroski, L. L., Faul, M. M., McCarthy, J. R.

Publikováno v: Journal of Medicinal Chemistry; June 2001, Vol. 44 Issue: 13 p2061-2064, 4p

Zobrazit plný text záznamu

Periodical

In vivo adenoviral delivery of recombinant human protein kinase C-zeta stimulates glucose transport activity in rat skeletal muscle.

Autor: Etgen, G J, Valasek, K M, Broderick, C L, Miller, A R

Publikováno v: Journal of Biological Chemistry; August 1999, Vol. 274 Issue: 32 p22139-42, 4p

Zobrazit plný text záznamu

Akademický článek

Human and rat amylin have no effects on insulin secretion in isolated rat pancreatic islets.

Autor: Broderick CL; Diabetes Research Division, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN 46285., Brooke GS, DiMarchi RD, Gold G

Publikováno v: Biochemical and biophysical research communications [Biochem Biophys Res Commun] 1991 Jun 28; Vol. 177 (3), pp. 932-8.

Zobrazit plný text záznamu

Akademický článek

Compound M & B 39890A [N-(3-imidazol-1-ylpropyl)- 2-(3-trifluoromethylbenezensulphonamido)-benzamide hydrochloride], a glucagon and insulin secretion inhibitor, improves insulin sensitivity in viable yellow obese-diabetic mice.

Autor: Yen TT; Lilly Research Laboratories, Eli Lilly and Co., Indianapolis, IN 46285., Schmiegel KK, Gold G, Williams GD, Dininger NB, Broderick CL, Gill AM

Publikováno v: Archives internationales de pharmacodynamie et de therapie [Arch Int Pharmacodyn Ther] 1991 Mar-Apr; Vol. 310, pp. 162-74.

Zobrazit plný text záznamu

Akademický článek

Antidiabetic activity of MTP-3115 in normal and diabetic mice.

Autor: Yen TT; Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285., Dininger NB, Broderick CL, Gill AM

Publikováno v: Archives internationales de pharmacodynamie et de therapie [Arch Int Pharmacodyn Ther] 1990 Nov-Dec; Vol. 308, pp. 137-48.

Zobrazit plný text záznamu

Akademický článek

AL-1576, an aldose reductase inhibitor (ARI), did not prevent the decrease of norepinephrine turnover in diabetic rats.

Autor: Yen TT; Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285., Fuller RW, Broderick CL, Hemrick-Luecke SK, Perry KW

Publikováno v: Research communications in chemical pathology and pharmacology [Res Commun Chem Pathol Pharmacol] 1988 Aug; Vol. 61 (2), pp. 257-60.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání